AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05054803 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administration of 2 Intrathecal infusions of placebo at day 1 and at 3 months
Study NCT04730817 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality Motor-Cognitive Training System
Description: Immersive VR training system tailor-made for the daily living experiences in the Hong Kong context to provide interactive experiences for older people in Hong Kong. The VR training system is designed as a game with 16 progressive levels (anticipating intervention group participants to complete 2 levels per week for 8 weeks) which aim to train their motor and cognitive functions.
Study NCT05175781 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine Hydrochloride
Description: is a sympatholytic drug that acts as an agonist of α2-adrenergic receptors in certain parts of the brain.
Study NCT05175781 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine Hydrochloride
Description: Ketamine is an NMDA receptor antagoni
Study NCT05175781 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal saline
Study NCT05020041 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity
Description: The schools in the intervention group will receive the online educational talk aimed at schoolchildren and a talk aimed at Physical Education teachers, given that they are fundamental for the development of habits in the school stage; besides, painted games will be implemented in the school playground.~The implementation of painted games will consist of adapting a space destined for recreation, designing a psychomotor circuit that does not require contact between peers or manipulation of objects in order to maintain COVID-19 sanitary and safety protocols. The psychomotor circuit includes a line circuit, a jumping sequence game, and a letter spiral. All the games will be implemented in a space within the educational establishment to which the students will have access during recess. The game designs involve activities to develop motor patterns such as jumping with different supports, running, and dynamic balance.
Study NCT03849534 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Soft occlusal appliance
Description: According to Best Practice in Sweden the soft occlusal appliance is ranked as gold standard for children with mixed or primary dentition
Study NCT03849534 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Jaw exercises
Description: The participants do three exercises twice a day. Open and closing mouth against resistance as well as stretch
Study NCT03849534 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Counseling
Description: The patients are instructed to minimize jaw parafunctions, chewing chewing gum etc, to do exercises, to take pain-killers or NSAIDs etc.
Study NCT04630977 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Multi-ingredient Pre-workout supplement
Description: Every important issue has been detailed before.
Study NCT04630977 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Progressive Resistance Training
Description: The information about it has been detailed in advance.
Study NCT04630977 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Progressive Resistance Training
Description: The information about it has been detailed in advance.
Study NCT04630977 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training
Description: The information about it has been detailed in advance.
Study NCT04630977 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Nutritional Patterns Guideline
Description: This intervention has also been described in advance.
Study NCT04630977 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nutritional Patterns Guideline
Description: This intervention has also been described in advance.
Study NCT05754164 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Attention Control Training
Description: Mobile app-based attention control training is an effective training method that can help people improve their ability to control attention. It is generally recommended to undergo 4 weeks of training, with 3-4 sessions per week and one day between each session. The specific operational method of this training may vary depending on different applications, but generally, training is presented in the form of a series of tasks. These tasks may involve aspects such as focusing attention, inhibiting interference, and reacting quickly.
Study NCT04630977 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutritional Patterns Guideline
Description: This intervention has also been described in advance.
Study NCT04744818 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Iron syrup
Description: Daily supplementation with iron
Study NCT04744818 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Multivitamin syrup
Description: Daily supplementation with multivitamins
Study NCT04744818 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Multivitamin syrup
Description: Daily supplementation with multivitamins
Study NCT05324306 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: combat application tourniquets (CAT)
Description: CAT tourniquets have been indicated for use in emergency situations revolving around a wounded limb, such as hemorrhage control.22-23 CAT tourniquets are the official tourniquet of the US Army since in 2005.~We will deploy well-studied and FDA approved combat application tourniquets (CAT) on both thighs of volunteer healthy adult subjects while measuring blood pressure in the upper extremities.
Study NCT06151808 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XTR006
Description: All participants will receive a single intravenous dose of 8.0-10.0mCi of XTR006 followed by PET scan
Study NCT06151808 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: XTR006
Description: All participants will receive a single intravenous dose of 8.0-10.0mCi of XTR006 followed by PET scan
Study NCT05426590 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Specular biomicroscopy
Description: Specular microscopy will be done before and 3 weeks after cataract surgery
Study NCT04890548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD3427
Description: Patients will receive 5 IA infusions of AZD3427 into the brachial artery. The IA infusions of AZD3427 will be administered via a syringe pump, using a polypropylene syringe containing 0.9% (w/v) saline and delivered through an administration set comprising a syringe, extension tubing (PVC), and a 0.2- or 0.22-μm PVDF syringe filter.
Study NCT04888962 — intervention group
Intervention type: OTHER
Intervention: OUD
Description: History of opioid use disorder.
Study NCT05798793 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab plus TP
Description: The participants will receive camrelizumab (200 mg) through intravenous infusion each 2-week cycle, and docetaxel (T) 75 mg/m2, cisplatin (P) 75 mg/m2 through intravenous infusion each 3-week cycle for 2 cycles.
Study NCT05798793 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TP
Description: The participants will receive docetaxel (T) 75 mg/m2, cisplatin (P) 75 mg/m2 through intravenous infusion each 3-week cycle for 2 cycles.
Study NCT06150170 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Proprioceptive training
Description: Proprioceptive exercises were applied to both groups. In addition to these exercises, balance, coordination and strengthening exercises will also be applied to both groups.
Study NCT06005545 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Passive Ultrasonic Irrigation (PUI) group
Description: Passive ultrasonic irrigation is the current golden standard in root canal cleaning and irrigation devices. It is used after root canal shaping using manual or rotary instruments. It uses sodium hypochlorite which is mobilized in the canal using ultrasonic non-cutting tips to clean, debride, disinfect, and prepare the root canal for obturation.
Study NCT06005545 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endoclean (EC) group
Description: Endoclean is a novel device that uses hydraulic inertial cavitation with the help of pressure and saline solution to debride the root canal after minimal shaping using manual or rotary shaping instruments. It is used to effectively clean, debride and prepare the root canal before obturation in the root canal treatment procedure.
Study NCT06005545 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional group
Description: Conventional root canal preparation uses manual or rotary files along with manual irrigation using syringes and irrigant solutions like sodium hypochlorite or EDTA to clean, debride and prepare the root canal for obturation.
Study NCT05441228 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Oculus Quest 2
Description: Oculus Quest 2 is virtual reality headset with 2 hand control remotes. Beat Saber application will be used on Oculus Quest 2.
Study NCT05441228 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Mirror therapy box
Description: Mirror therapy is provided by mirror therapy box by placing it in sagittal plane of patient.
Study NCT04642248 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Personalized Run Practice
Description: A combination of drills, flexibility, and strength activities combined with a gait retraining program
Study NCT04642248 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Personalized Run Practice
Description: A combination of drills, flexibility, and strength activities combined with a gait retraining program
Study NCT04824495 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sample
Description: Blood samples at different timepoints during SARS-CoV2 infection
Study NCT05179213 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: 75 mg/m2 subcutaneously on days 1-7
Study NCT05179213 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chidamide
Description: 20mg orally per week continuously
Study NCT06486792 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apixaban
Description: Patients who have had an ischemic stroke will receive either an anticoagulant or aspirin according to their randomization arm.
Study NCT06486792 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aspirin
Description: Aspirin is used as the standard of care
Study NCT03457051 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Total Knee Arthroplasty (TKA)
Description: In total (complete) knee arthroplasty (TKA), the orthopaedic surgeon removes the damaged areas of the knee and replaces the components with an artificial joint. The device that will be used is: Stryker TKA Triathlon system implant Cruciate retaining radius femur design. This device has been approved for use by Health Canada.
Study NCT03457051 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Unicompartmental Knee Arthroplasty (UKA)
Description: Unicompartment (partial) knee arthroplasty (UKA) has been available for over 40 years and differs from TKA in that only the most affected and symptomatic compartment (most commonly medial, but occasionally lateral and patella femoral) are replaced. The device that will be used is: Stryker PKR implant cemented and fixed bearing design. This device has been approved for use by Health Canada.
Study NCT05298059 — intervention group
Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: Laser of low frequncy
Description: Apply the laser at three points on each tooth.
Study NCT05298059 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: CPP-ACPF
Description: Apply MI paste plus for five minutes, in the vestibular surface os teeth. During this time patientes should be with closed mounth ad should not talk or to split.
Study NCT04636736 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: HIV drug resistance testing
Description: HIV drug resistance testing in people newly diagnosed in HIV in Poland
Study NCT05534139 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 7T MRI-scan
Description: MRI-scanning of the brain using a 7T-MRI scanner
Study NCT05534139 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: CSF collection via lumbar puncture
Description: CSF is collected by doing a lumbar puncture
Study NCT05534139 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood withdrawal
Description: Blood is collected by doing a blood withdrawal
Study NCT05534139 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Clinical measures
Description: UHDRS-Total motor score, UHDRS-short problem behaviour assessment, UHDRS-Cognitive assessments
Study NCT06086990 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Contigo Application
Description: Contigo, a smartphone app, focuses on two main goals: monitoring cancer patients for early signs of drug toxicity and offering educational content to empower them in managing clinical challenges linked to their diagnosis and treatment. Monitoring involves patients inputting experiences via oncology-related questionnaires, with weekly checks for chemotherapy toxicity using a validated questionnaire (PRO-CTCAE). Severe cases trigger alerts, while milder ones receive educational guidance. Data collected is shared with healthcare providers. Educational content, backed by scientific evidence and expert collaboration, covers cancer-specific topics and healthcare processes to enhance patients' self-awareness and self-care practices.
Study NCT04795063 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Total Robotic Distal Gastrectomy
Description: All the surgical procedures are performed using the robot system.
Study NCT04795063 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Robotic-Assisted Distal Gastrectomy
Description: After finishing the lymphadenectomy, the digestive tract reconstruction is performed extracorporal.
Study NCT03523156 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azithromycin mass treatment
Description: Standard of care annual community-wide mass drug administration (MDA) will be provided at the normally scheduled time.
Study NCT03523156 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azithromycin mass treatment
Description: Standard of care annual community-wide mass drug administration (MDA) will be provided at the normally scheduled time.
Study NCT03523156 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azithromycin targeted treatment
Description: Two rounds of treatment targeted to all children aged 2 to 9 years old. The first targeted round will be 1-2 weeks after the community-wide MDA and the second round will occur another 1-2 weeks later.
Study NCT04553666 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epigallocatechin-3-Gallate (EGCG) plus Ascorbic Acid (Vitamin C)
Description: 800mg Epigallocatechin-3-Gallate (EGCG) plus 250mg Ascorbic Acid (Vitamin C) taken one time a day for twelve weeks
Study NCT06235112 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electronic health record-based notification of Nanox.AI Coronary Artery Calcification Assessment
Description: The intervention involves electronic health record, email, or letter notification about the presence of coronary artery calcification on chest CT and recommendation of preventive therapy. This is based on results of the automatic detection of coronary artery calcification from AI device (software).
Study NCT06165432 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topical Benzocaine
Description: Benzocaine topical anesthetic gel will be used a pre-injection anesthetic on one half of the palate before giving greater palatine nerve block
Study NCT06165432 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Topical ice
Description: For the other half of the palate topical ice would be used before greater palatine nerve block
Study NCT05793749 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prophylactic lymphedema treatment
Description: 1. perform manual lymphatic drainage twice a week after the start of radiotherapy for a total of 10 times, and wear lymphedema compression stockings after each manual lymphatic drainage, 2. teach patients how to care for their skin. 3. perform functional exercises for lymphedema of the lower extremities twice a day for 15 \~ 20 minutes each time. 4. follow up observation: before the start of radiotherapy, every Friday during radiotherapy, and every 3 months after the end of radiotherapy, the occurrence of lymphedema and related symptoms and quality of life were evaluated.
Study NCT04869592 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)
Description: Intramuscular injection of low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell) in the deltoid muscle of the upper arm
Study NCT04869592 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: high-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)
Description: Intramuscular injection of high-dose Recombinant SARS-CoV-2 Vaccine (CHO cell) in the deltoid muscle of the upper arm
Study NCT04869592 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Intramuscular injection of placebo in the deltoid muscle of the upper arm
Study NCT05673447 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anti-CD19 CAR NK cells
Description: Patients will receive Fludarabine (30 mg/m2 per day) and Cyclophosphamide (300mg/m2 per day) on day -5, -4, and -3. Doses of 6×10\^8, 1×10\^9, 1.5×10\^9 Anti-CD19 CAR NK cells will infused in each group using the 3 + 3 dose-escalation strategy.
Study NCT04140773 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: D-serine
Description: Capsule D-serine
Study NCT04140773 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsule D-serine
Study NCT05654571 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: mammography
Description: All patients are checked for mammography every year after surgery.
Study NCT05861830 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: The combination of Dalpiciclib with physician-selected endocrine therapy
Description: * Dalpiciclib: 150 mg, orally, once daily, on days 1-21, every 28 days (3 weeks on, 1 week off)~* Letrozole: 2.5 mg, orally, once daily (continuous), every 28 days OR Anastrozole: 1.0 mg, orally, once daily (continuous), every 28 days OR Exemestane: 25 mg, orally, once daily (continuous), every 28 days OR Fulvestrant: 500 mg, intramuscular injection on day 1/15 of the first cycle, then on day 1 of each subsequent cycle, every 28 days OR Tamoxifen: 10-20 mg, orally, twice daily (continuous), every 28 days~* Pre/perimenopausal women also require ovarian function suppression (OFS), which can be achieved through bilateral oophorectomy or the use of gonadotropin-releasing hormone (GnRH) analog drugs
Study NCT05861830 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy selected by the physician
Description: The chemotherapy regimen is chosen by the clinical physician and may include, but is not limited to, the following options: the combination of paclitaxel and capecitabine, the combination of paclitaxel and carboplatin, single-agent capecitabine, single-agent platinum drugs, and the combination of gemcitabine and platinum-based chemotherapy. Each treatment cycle consists of a 21-day duration.
Study NCT06365788 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abemaciclib
Description: 150 mg tablet orally twice daily
Study NCT06365788 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bicalutamide
Description: 150 mg tablet orally once daily
Study NCT05945212 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vibration
Description: The program will take place over 40 sessions : 5 sessions per week, for 2 months (40 sessions in total over 8 weeks during the hospitalization in the department); this group will benefit from an effective vibration of a frequency of 100Hz
Study NCT05945212 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham vibration
Description: The program will take place over 40 sessions: 5 sessions per week, for 2 months (40 sessions in total over 8 weeks during hospitalization in the department); this group will not benefit from effective vibration.
Study NCT05945212 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 10 meters Walk Test
Description: Short-distance ambulation speed is measurement between 2 markers on the ground 10 meters apart in a corridor with flat ground, the patient starting his walk 3 meters before to have a launched march disregarding markers, and ends 3 meters After. The stopwatch is started when the markers are crossed.
Study NCT05945212 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: 10 meters Walk Test
Description: Short-distance ambulation speed is measurement between 2 markers on the ground 10 meters apart in a corridor with flat ground, the patient starting his walk 3 meters before to have a launched march disregarding markers, and ends 3 meters After. The stopwatch is started when the markers are crossed.
Study NCT05945212 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 2 Minute Walk Test (2MWT)
Description: Long-distance ambulation speed is measured from a standing start and the test involves asking the patient to walk as far as possible in 2 minutes.
Study NCT05945212 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: 2 Minute Walk Test (2MWT)
Description: Long-distance ambulation speed is measured from a standing start and the test involves asking the patient to walk as far as possible in 2 minutes.